glp 1 lean mass loss Weighing the risk of GLP-1 treatment in older adults: Should we be concerned about sarcopenic obesity? motus™ ~ Produces Weight Loss

Sarria B, Martinez-Lopez S, Garca-Cordero J, Gonzalez-Ramila S, Mateos R, and Bravo L

Huynh G, Runeberg H, Weideman R

However, in a randomized placebo-controlled pilot study in adults with obesity on liraglutide for 1 year (average 12% weight loss on liraglutide), the addition of phentermine did not provide meaningful additional weight loss compared to placebo [10]

They found that the GLP-1 semaglutide did not improve executive function in MDD

Your unique circumstances are always taken into account and should be evaluated by a qualified professional

Future anti-obesity agents for use in older adults Several novel AOMs are currently in development, or undergoing clinical trials, that will likely be available for the treatment of obesity soon, and have included older adult participants (Table 1)